Skip to main content
Clinical Trials/NCT00977158
NCT00977158
Withdrawn
Not Applicable

Microbiota of the Respiratory Flora in Children With Cystic Fibrosis During the First Year of Life

Tufts Medical Center2 sites in 1 countryMay 2011
ConditionsCystic Fibrosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cystic Fibrosis
Sponsor
Tufts Medical Center
Locations
2
Primary Endpoint
To characterize the microbial ecology and changes in bacterial diversity of the oropharynx in a cohort of children with CF during the first year of life using 16S rRNA sequence analysis
Status
Withdrawn
Last Updated
11 years ago

Overview

Brief Summary

The goal of this study is characterize the changes in bacterial diversity of the upper respiratory tracts of infants with cystic fibrosis (CF). Another goal is to determine when CF patients become colonized with pathogenic bacteria that are responsible for the lethal lung damage in children with CF. Ten subjects will be recruited into the study. Throat swabs will be collected at 6-8 weeks of age, 3 months, 6 months, 9 months, and 12 months of age in order to chart any changes in the bacterial populations of the respiratory tract. Clinical data will also be collected to evaluate the possible influence of external factors on changes in the microbial communities. This study will provide preliminary data on whether probiotics can eradicate the colonization of the respiratory tract by pathogenic bacteria.

Registry
clinicaltrials.gov
Start Date
May 2011
End Date
TBD
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Male and female subjects, newborn to age 3 months
  • Have a diagnosis of cystic fibrosis (Diagnosis of CF will be based on either a positive sweat chloride of \>60 mEq/L or the identification of two detectable mutations associated with CF
  • Parent/guardian plans to have follow-up care for approximately one year at designated CF clinic
  • Parent/guardian provides informed consent to participate in the study

Exclusion Criteria

  • Contraindications for obtaining oropharyngeal swabs

Outcomes

Primary Outcomes

To characterize the microbial ecology and changes in bacterial diversity of the oropharynx in a cohort of children with CF during the first year of life using 16S rRNA sequence analysis

Time Frame: 6-8 weeks of age, 3 months, 6 months, 9 months, and 12 months of age

To describe the clinical variables that may be associated with changes in microbial ecology in children with cystic fibrosis over the first year of life

Time Frame: 6-8 weeks of age, 3 months, 6 months, 9 months, and 12 months of age

To explore changes in the microbial ecology of the oropharynx in conjunction with Staphylococcus aureus colonization in children with CF

Time Frame: 6-8 weeks of age, 3 months, 6 months, 9 months, and 12 months of age

Study Sites (2)

Loading locations...

Similar Trials